Amgen Inc.
DKK1 ANTIBODIES AND METHODS OF USE
Last updated:
Abstract:
The present invention provides antibodies and immunologically functional fragments thereof that specifically bind DKK1 polypeptides. Methods for preparing such antibodies or fragments thereof as well as physiologically acceptable compositions containing the antibodies or fragments are also provided. Use of the antibodies and fragments to treat various diseases are also disclosed.
Status:
Application
Type:
Utility
Filling date:
9 Sep 2020
Issue date:
11 Feb 2021